Amgen Inc. (AMGN) Stock Analysis

Free AI-powered analysis and research for Amgen Inc. stock

Sector: Healthcare

Analyze Amgen Inc. (AMGN) Stock

Amgen Inc. (AMGN) is a leading company in the Healthcare sector. Use StockIQ's free analysis tool to get comprehensive insights into AMGN stock performance, technical indicators, and AI-powered trading recommendations.

Get instant AI-powered analysis including technical indicators, fundamental analysis, risk assessment, and trading insights for Amgen Inc. stock.

📰 Latest Update

Watch Out, Eli Lilly and Novo Nordisk: Amgen's Monthly Weight Loss Drug Has 6 Phase 3 Trials Running -- and It's Coming for Your Patients

Wed, July 29, 2026 at 11:50 AM UTC 4 min read

Amgen is advancing its weight loss drug, currently in six Phase 3 clinical trials, positioning itself to compete with established players like Eli Lilly and Novo Nordisk. This development is significant for investors as successful trials could lead to a strong market entry, potentially capturing a share of the lucrative weight loss market. The outcome of these trials will be crucial in determining Amgen's growth trajectory and market valuation.

Read full article →

Why Analyze Amgen Inc. (AMGN) with StockIQ?

• ✅ Free AI-powered analysis of Amgen Inc. (AMGN) stock
• ✅ Real-time technical indicators for Amgen Inc. stock
• ✅ Comprehensive risk assessment for AMGN
• ✅ No credit card required

People also watch